Concepedia

Publication | Open Access

APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma

DOIFull Paper Access

97

Citations

33

References

2015

Year

David S H Liu, Matthew Read, Carleen Cullinane, Walid J. Azar, Christina M. Fennell, Karen G. Montgomery, Sue Haupt, Ygal Haupt, Klas G. Wiman, Cuong Duong,
Gut

Abstract

APR-246 has significant antitumour activity in OAC. Given that APR-246 is safe at therapeutic levels our study strongly suggests that APR-246 can be translated into improving the clinical outcomes for OAC patients.

References

YearCitations

Page 1